Clinical Trial Update: Growth Hormone for the Treatment of Gastroparesis [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 study sponsored by Mayo Clinic is evaluating growth hormone for treating gastroparesis; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroparesis

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Mayo Clinic | Conditions: Gastroparesis | EARLY_Phase 1 | Status: RECRUITING